MyoView launched in Japan:
This article was originally published in Clinica
Nihon Medi-Physics launched Amersham's MyoView Injectable heart imaging agent in Japan this month. MyoView Injectable is a ready-to-inject conjugate form of MyoView technetium-based tetrofosmin. The injectable agent was approved by the Ministry of Health and Welfare for manufacture and sale in Japan last October (see Clinica No 726, p 16). MyoView in kit form was launched in Japan and Europe in 1994 and in the US in 1996.